Sort   by:  
 Page size 
Following extensive treatment with androgen receptor (AR) pathway inhibitors, a significant number of metastatic prostate cancer develop treatment resistance, and approximately 20% of these castration-resistant prostate cancers (CRPC) transdifferentiate, at least partially, into neuroendocrine (NE) ...
ORGANISM(S): Homo sapiens (Human) 
2025-06-12 | PXD061080 | Pride
Following extensive treatment with androgen receptor (AR) pathway inhibitors, a significant number of metastatic prostate cancer develop treatment resistance, and approximately 20% of these castration-resistant prostate cancers (CRPC) transdifferentiate, at least partially, into neuroendocrine (NE) ...
ORGANISM(S): Homo sapiens (Human) 
2025-06-12 | PXD061127 | Pride
LSD1 inhibtion in NEPC cell line models.
Spatial transcriptomics of de novo NEPC and ARPC
KDM4A promotes NEPC progression through regulation of MYC expression [ChIP-seq]
EZH2 knockout and rescue in WCM154 NEPC organoid model. [RNA-Seq]
Targeting serotonin-driven histone serotonylation suppresses lineage plasticity and progression of NEPC
Lysine-specific demethylase 1 (LSD1) is a histone demethylase that promotes stemness and cancer cell survival, including in prostate cancer. Most prostate malignancies are adenocarcinomas with luminal differentiation. However, a subset of tumors undergoes cellular reprogramming to a more lethal neur...
ORGANISM(S): Homo sapiens 
2023-08-30 | GSE218993 | GEO
Sort   by:  
 Page size